202 related articles for article (PubMed ID: 2891333)
21. Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong.
Tubercle; 1975 Jun; 56(2):81-96. PubMed ID: 1103400
[TBL] [Abstract][Full Text] [Related]
22. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
23. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study.
Tubercle; 1986 Mar; 67(1):5-15. PubMed ID: 3521015
[TBL] [Abstract][Full Text] [Related]
24. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.
Tuber Lung Dis; 1992 Feb; 73(1):59-67. PubMed ID: 1326349
[TBL] [Abstract][Full Text] [Related]
25. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.
Am Rev Respir Dis; 1979 Apr; 119(4):579-85. PubMed ID: 375787
[TBL] [Abstract][Full Text] [Related]
26. Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy.
Lancet; 1979 Jun; 1(8131):1361-3. PubMed ID: 87829
[TBL] [Abstract][Full Text] [Related]
27. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.
Mitchison DA; Nunn AJ
Am Rev Respir Dis; 1986 Mar; 133(3):423-30. PubMed ID: 2420242
[TBL] [Abstract][Full Text] [Related]
28. Short-course drug therapy for tuberculosis.
Stratton MA; Reed MT
Clin Pharm; 1986 Dec; 5(12):977-87. PubMed ID: 3542345
[TBL] [Abstract][Full Text] [Related]
29. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175
[TBL] [Abstract][Full Text] [Related]
30. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA
Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398
[TBL] [Abstract][Full Text] [Related]
31. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
Am Rev Respir Dis; 1984 Jun; 129(6):921-8. PubMed ID: 6375490
[TBL] [Abstract][Full Text] [Related]
32. A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. Tanzania/British Medical Research Council Collaborative Investigation.
S Afr Med J; 1996 Aug; 86(8):960-5. PubMed ID: 8823423
[TBL] [Abstract][Full Text] [Related]
33. Controlled clinical trial of two 6-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Tanzania/British Medical Research Council Study.
Am Rev Respir Dis; 1985 May; 131(5):727-31. PubMed ID: 3890640
[TBL] [Abstract][Full Text] [Related]
34. A controlled trial of 2-month, 3-month, and 12-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 60 months.
Am Rev Respir Dis; 1984 Jul; 130(1):23-8. PubMed ID: 6377997
[TBL] [Abstract][Full Text] [Related]
35. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
[TBL] [Abstract][Full Text] [Related]
36. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
Teo SK
Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
[TBL] [Abstract][Full Text] [Related]
37. 4-, 5- and 6-month regimens containing isoniazid, rifampicin, pyrazinamide and streptomycin for treatment of pulmonary tuberculosis under program conditions in Hong Kong.
Chan SL; Wong PC; Tam CM
Tuber Lung Dis; 1994 Aug; 75(4):245-50. PubMed ID: 7949069
[TBL] [Abstract][Full Text] [Related]
38. Short-course chemotherapy of pulmonary tuberculosis in pneumoconiotic patients.
Lin TP; Suo J; Lee CN; Lee JJ; Yang SP
Am Rev Respir Dis; 1987 Oct; 136(4):808-10. PubMed ID: 3310770
[TBL] [Abstract][Full Text] [Related]
39. Controlled clinical trial of 4 short-couse regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis.
Tubercle; 1983 Sep; 64(3):153-66. PubMed ID: 6356538
[TBL] [Abstract][Full Text] [Related]
40. Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Second report. Third East African/British Medical Research Council Study.
Tubercle; 1980 Jun; 61(2):59-69. PubMed ID: 6159711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
